Disarming Felons Act

H.R.5378, Lower Cost More Transparency Act, Entirety Monitor the following: H.R.3290, 340B Transparency Act, Entirety H.R.2369, To amend the Federal Food, Drug, and Cosmetic Act with respect to in vitro clinical tests, and for other, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Laboratory infrastructure; Diagnostic Laboratory Testing issues Mental Health initiatives Center for Excellence in Improving Diagnosis legislation P.L.117-2, American Rescue Plan Act of 2021, Hospital and healthcare funding eligibility related issues Surprise Billing Health Care Transparency Prescription Drug Supply Chain issues Disproportionate Share Hospital (DSH) ARPA-H Proposal Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES

H.R.5378, Lower Cost More Transparency Act, Entirety Monitor the following: H.R.3290, 340B Transparency Act, Entirety Mental Health initiatives 340B generally P.L.117-2, American Rescue Plan Act of 2021, Hospital and healthcare funding eligibility related issues American Jobs Plan, Health related infrastructure Surprise Billing Health Care Transparency Prescription Drug Cost Disproportionate Share Hospital (DSH) Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES

H.R. 198: Drug Pricing Transparency and Accountability Act - Provisions related to the 340B Program H.R. 830/ S. 1375: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes H.R. 1790: Biologics Competition Act of 2023 - To direct the Secretary of Health and Human Services to evaluate the extent to which the substitution of interchangeable biological products is impacted by differences between the system for determining a biological product to be interchangeable and the system for assigning therapeutic equivalence ratings to drugs, and for other purposes H.R. 2500: Protecting Americans from Unsafe Drugs Act of 2023 H.R. 2679: Pharmacy Benefit Manager Accountability Act H.R. 2816: Pharmacy Benefit Manager Sunshine and Accountability Act H.R. 2940/S 1355 PASTEUR Act/Incentives to increase novel antibiotic medicines H.R. 2880: Protecting Patients Against PBM Abuses Act H.R. 3008: Drug Shortage Prevention Act of 2023 H.R. 3281: Transparent PRICE Act H.R. 3285: Fairness for Patient Medications Act H.R. 3290: To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program/Transparency Legislation H.R. 3433: Give Kids a Chance Act of 2023 H.R. 3561: Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or PATIENT Act of 2023 H.R. 3791: Improving DATA in Public Health Act H.R. 3793: Ensuring Access to Lifesaving Drugs Act of 2023 H.R. 3810: Drug Origin Transparency Act of 2023 H.R. 4390: Protect 340B Act - Provisions related to 340B Program (117th Congress) H.R. 5376: Inflation Reduction Act of 2022 (P.L. 117-169)/Implementation of $0 Vaccine co-pay; maximum fair price provisions H.R. 7032: Increasing Transparency in Generic Drug Applications Act of 2022 - This bill requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why) (117th Congress) H.R. 7653: Modern Authentication of Pharmaceuticals Act of 2022 (117th Congress) S. 6: Biosimilar Red Tape Elimination Act (117th Congress) S. 113: Prescription Pricing for the People Act of 2023 - Provisions related to PBMs S. 127: Pharmacy Benefit Manager Transparency Act of 2023 - Provisions related to PBMs S. 148: Stop STALLING Act - Provisions related to citizen petitions S. 315: Taxpayer Research And Contributions Knowledge Act of 2023 or TRACK Act of 2023 - To direct the Secretary of Health and Human Services and other Federal officials to compile into a searchable database information relating to Federal support for biomedical research and development, and for other purposes. S. 476: Maintaining Investments in New Innovation Act S. 775: Increasing Transparency in Generic Drug Applications Act S. 1128: Ensuring Access to Generic Medications Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 - Provisions related to drug pricing (117th Congress) S. 1967: Patients Before Middlemen (PBM Act) S. 1067: Ensuring Timely Access to Generics Act of 2023 S. 1114: Expanding Access to Low-Cost Generics Act 2023 S. 1214: RARE Act - To set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions S. 1264: SMART Prices Act - Provisions related to drug pricing reform S. 1339: Pharmacy Benefit Manager Reform Act - Provisions related to PBMs S. 1355: PASTEUR Act of 2023 - Provisions related to antimicrobial resistance policy issues S. 1375: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes S. 1542: Delinking Revenue from Unfair Gouging Act or DRUG Act - Provisions related to PBMs S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act or PREVENT Pandemics Act (117th Congress) Pharmacy Benefit Manager reform and policy issues Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) Cancer Moonshot Initiative 21st Century Cures 2.0 Drug cost and pricing policy issues Principles for drug pricing reform Drug importation policy issues Accelerated approval policy issues FDA regulatory approval authority policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance (AMR) policy issues Mental health policy issues High deductible health plans/HSA policy issues Supply chain policy issues Real world evidence policy issues Clinical trial diversity policy issues Prescription drug abuse policy issues 340B drug discount program policy issues Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues COVID-19 policy issues Pandemic preparedness policy issues Defense Production Act policy issues Cybersecurity policy issues Anticounterfeiting policy issues Chronic Kidney Disease Improvement in Research and Treatment Act. H.R.2534 - PROTECT 340B Act of 2023 House Draft Language for PAHPA Reauthorization HR 3665 - Defending American Jobs and Investment Act Senate Draft Language for PAHPA Reauthorization Pandemic and All Hazards Preparedness Act reauthorization (discussion draft) Labor HHS appropriations (ongoing discussion) Under Taxed Profit Rule, Ways and Means Committee discussion Vaccine Injury Compensation Program reform discussion

H.R. 198: Drug Pricing Transparency and Accountability Act - Provisions related to the 340B Program H.R. 830: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes H.R. 1790: Biologics Competition Act of 2023 - To direct the Secretary of Health and Human Services to evaluate the extent to which the substitution of interchangeable biological products is impacted by differences between the system for determining a biological product to be interchangeable and the system for assigning therapeutic equivalence ratings to drugs, and for other purposes H.R. 2500: Protecting Americans from Unsafe Drugs Act of 2023 H.R. 2534: PROTECT 340B Act of 2023 - Provisions related to the 340B program H.R. 2679: Pharmacy Benefit Manager Accountability Act H.R. 2816: Pharmacy Benefit Manager Sunshine and Accountability Act H.R. 2880: Protecting Patients Against PBM Abuses Act H.R. 3008: Drug Shortage Prevention Act of 2023 H.R. 3281: Transparent PRICE Act H.R. 3285: Fairness for Patient Medications Act H.R. 3290: To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program H.R. 3433: Give Kids a Chance Act of 2023 H.R. 3561: Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or PATIENT Act of 2023 H.R. 3791: Improving DATA in Public Health Act H.R. 3793: Ensuring Access to Lifesaving Drugs Act of 2023 H.R. 3810: Drug Origin Transparency Act of 2023 H.R. 5376: Inflation Reduction Act of 2022 (P.L. 117-169) H.R. 7032: Increasing Transparency in Generic Drug Applications Act of 2022 (117th Congress) H.R. 7653: Modern Authentication of Pharmaceuticals Act of 2022 (117th Congress) S. 6: Biosimilar Red Tape Elimination Act (117th Congress) S. 113: Prescription Pricing for the People Act of 2023 - Provisions related to PBMs S. 127: Pharmacy Benefit Manager Transparency Act of 2023 - Provisions related to PBMs S. 148: Stop STALLING Act - Provisions related to citizen petitions S. 315: Taxpayer Research And Contributions Knowledge Act of 2023 or TRACK Act of 2023 - To direct the Secretary of Health and Human Services and other Federal officials to compile into a searchable database information relating to Federal support for biomedical research and development, and for other purposes S. 476: Maintaining Investments in New Innovation Act S. 775: Increasing Transparency in Generic Drug Applications Act S. 1128: Ensuring Access to Generic Medications Act S. 935: Fair Accountability and Innovative Research Drug Pricing Act of 2023 - Provisions related to drug pricing S. 1067: Ensuring Timely Access to Generics Act of 2023 S. 1114: Expanding Access to Low-Cost Generics Act 2023 S. 1214: RARE Act - To set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions S. 1264: SMART Prices Act - Provisions related to drug pricing reform S. 1339: Pharmacy Benefit Manager Reform Act - Provisions related to PBMs S. 1355: PASTEUR Act of 2023 - Provisions related to antimicrobial resistance policy issues S. 1375: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes S. 1542: Delinking Revenue from Unfair Gouging Act or DRUG Act - Provisions related to PBMs S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act or PREVENT Pandemics Act (117th Congress) Pharmacy Benefit Manager reform and policy issues Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) Cancer Moonshot Initiative 21st Century Cures 2.0 Drug cost and pricing policy issues Principles for drug pricing reform Drug importation policy issues Accelerated approval policy issues FDA regulatory approval authority policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance (AMR) policy issues Mental health policy issues High deductible health plans/HSA policy issues Supply chain policy issues Real world evidence policy issues Clinical trial diversity policy issues Prescription drug abuse policy issues 340B drug discount program policy issues Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues COVID-19 policy issues Pandemic preparedness policy issues Defense Production Act policy issues Cybersecurity policy issues Anticounterfeiting policy issues

H.R.3290, 340B Transparency Act, Entirety Monitor the following: Mental Health initiatives 340B generally P.L.117-2, American Rescue Plan Act of 2021, Hospital and healthcare funding eligibility related issues American Jobs Plan, Health related infrastructure Surprise Billing Health Care Transparency Prescription Drug Cost Disproportionate Share Hospital (DSH) Federal Medicaid Assistance Percentages (FMAP) Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES

H.R.3290, 340B Transparency Act, Entirety Monitor the following: H.R.2369, To amend the Federal Food, Drug, and Cosmetic Act with respect to in vitro clinical tests, and for other, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Laboratory infrastructure; Diagnostic Laboratory Testing issues Mental Health initiatives Center for Excellence in Improving Diagnosis legislation P.L.117-2, American Rescue Plan Act of 2021, Hospital and healthcare funding eligibility related issues Surprise Billing Health Care Transparency Prescription Drug Cost Disproportionate Share Hospital (DSH) CURES 2.0, Health services delivery; and Research and development issues ARPA-H Proposal Public Law 117-169, Inflation Reduction Act of 2022, Implementation issues

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES

Violent crime, law enforcement recruitment and retention, community policing, law enforcement grants, law enforcement funding, gun violence, crime victims services, drug sentencing reform, substance abuse disorders, law enforcement policy and operations, criminal justice reform, NICS background checks, drug trafficking, border security and immigration, officer health and wellness, policing reform, 1033 Program, law enforcement vehicles, emergency communications, law enforcement communications, Department of Justice appropriations, criminal record sealing and expungement, ghost guns, federal and local law enforcement partnerships, encryption and lawful access, federal cocaine sentencing disparity, cybersecurity and cybercrime, move over laws, firearms policy, civil rights and civil liberties, mental health crisis training and response, crisis intervention teams, red flag laws, community violence intervention, assault weapon ban, fentanyl scheduling, Project Safe Neighborhoods, forensic science, violence against law enforcement, domestic violence and the boyfriend loophole, organized retail theft, child abuse prevention, community reentry, bail reform and inmate release, supervised release, criminal justice system accountability, Next Generation 911, FirstNet, juvenile sentencing, de-escalation training, H.R. 5768/S. 4402 - VICTIM Act of 2021, H.R. 7826 - Pathways to Policing, H.R. 8209 - SOBER Act of 2022, H.R.6538 - Active Shooter Alert Act of 2022, H.R. 7394 - Women in Criminal Justice Act, H.R.8118 - Aaron Salter, Jr., Responsible Body Armor Possession Act, H.R. 3290 - Disarming Felons Act, H.R. 2992/S. 4286 - TBI and Law Enforcement Training Act, H.R.6375 - COPS on the Beat Grant Program Reauthorization and Parity Act of 2022, S.3782/H.R. 7300 - Dark Web Interdiction Act of 2022, H.R. 6667 - Fresh Start Act, H.R. 7462 - EMAP Act, S. 2502/H.R.1924 - Kenneth P. Thompson Begin Again Act, S. 2629 - Better Cybercrime Metrics Act, S.2938 - Bipartisan Safer Communities Act, S.1395 - Age 21 Act, S. 4287 - COPS Parity Act, S.4003 - Law Enforcement De-Escalation Training Act of 2022, S. 4151 - Stop Pills that Kill, S. 312 - COVID-19 Safer Detention Act of 2021, S. 661 -Prohibiting Punishment of Acquitted Conduct Act of 2021, S. 1014 - First Step Implementation Act, S.4116 - SMART Cocaine Sentencing Act, S.1380 - Clean Slate Act of 2021, S.4091 - Overdose Review Team Act, S. 79/H.R. 1693-EQUAL Act, S.3975 - Victims of Child Abuse Act Reauthorization Act of 2022, S.3846 - Justice and Mental Health Collaboration, S. 4007, Fighting Post-Traumatic Stress Disorder Act of 2022, S. 3860 - Invest to Protect Act, S. 2151 - Stronger Communities Act, S. 3635, Public Safety Officer Support Act of 2022, S.3981 - Improving Law Enforcement Officer Safety and Wellness Through Data Act, H.R. 6768 - FirstNet Reauthorization

Violent crime, community policing, law enforcement grants, law enforcement funding, gun violence, crime victims services, law enforcement policy and operations, criminal justice reform, NICS background checks, drug trafficking, Department of Justice appropriations, criminal record sealing and expungement, ghost guns, federal and local law enforcement partnerships, firearms policy, civil rights and civil liberties, red flag laws, community violence intervention, assault weapon ban, Project Safe Neighborhoods, forensic science, violence against law enforcement, domestic violence and the boyfriend loophole, bail reform and inmate release, supervised release, criminal justice system accountability, juvenile sentencing, H.R. 5768/S. 4402 - VICTIM Act of 2021, H.R.6538 - Active Shooter Alert Act of 2022, H.R.8118 - Aaron Salter, Jr., Responsible Body Armor Possession Act, H.R. 3290 - Disarming Felons Act, H.R. 6667 - Fresh Start Act, S.2938 - Bipartisan Safer Communities Act, S.1395 - Age 21 Act, S. 312 - COVID-19 Safer Detention Act of 2021, S. 661 - Prohibiting Punishment of Acquitted Conduct Act of 2021, S. 1014 - First Step Implementation Act, S.1380 - Clean Slate Act of 2021, S. 3635, Public Safety Officer Support Act of 2022, S.3981 - Improving Law Enforcement Officer Safety and Wellness Through Data Act,

Client expense: $30,000 · Firm income: Not reported